+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients



Incidence of tardive dyskinesia with typical versus atypical antipsychotics in very high risk patients



Neurology 60(5 Suppl. 1): A126



Background: Our aim was to study the risk of developing tardive dyskinesia in highly vulnerable patients (i.e., middle-aged and older adults with borderline dyskinesia) treated with conventional versus atypical antipsychotics. Methods: We examined the cumulative incidence of definitive tardive dyskinesia at 1, 3, and 6 months during antipsychotic treatment among 240 outpatients at least 45 years of age who had borderline tardive dyskinesia at baseline. Results: Patients treated with conventional antipsychotics were approximately two times more likely to develop definitive tardive dyskinesia during the study period compared with those treated with atypical antipsychotics (p<.001). This difference was found despite patients in the atypical antipsychotic group being significantly older and having more severe extrapyramidal symptoms at baseline than those prescribed typical antipsychotics. Conclusions: Among patients at a very high risk for worsening tardive dyskinesia, the use of atypical antipsychotics was associated with a significantly lower risk of developing definitive tardive dyskinesia compared with conventional antipsychotics.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 010820822

Download citation: RISBibTeXText

PMID: 12814866

DOI: 10.1016/s0006-3223(03)00170-7


Related references

Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 2: Incidence and management strategies in patients with schizophrenia. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 50(11): 703-714, 2005

The effect of atypical versus typical antipsychotics on tardive dyskinesia: a naturalistic study. European Archives of Psychiatry and Clinical Neuroscience 257(3): 169-172, 2006

Incidence of tardive dyskinesia is lower with quetiapine treatment than with typical antipsychotics in patients with schizophrenia and schizoaffective disorder. Schizophrenia Research 41(1): 206-207, 2000

Incidence of persistent tardive dyskinesia may be lower with quetiapine treatment than previously reported with typical antipsychotics in patients with psychoses. Neurology 54(7 Supp 3): A51, 2000

Tardive dyskinesia in the era of typical and atypical antipsychotics. Part 1: pathophysiology and mechanisms of induction. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie 50(9): 541-547, 2005

Review of incidence studies of tardive dyskinesia associated with typical antipsychotics. Journal of Clinical Psychiatry 61(Suppl. 4): 15-20, 2000

Expected incidence of tardive dyskinesia associated with atypical antipsychotics. Journal of Clinical Psychiatry 61(Suppl. 4): 21-26, 2000

Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. Journal of Clinical Psychiatry 65(Suppl. 9): 16-20, 2004

Focus on lower risk of tardive dyskinesia with atypical antipsychotics. Annals of Clinical Psychiatry 18(1): 57-62, 2006

Can atypical antipsychotics improve tardive dyskinesia associated with other atypical antipsychotics? Case report and brief review of the literature. Journal of Psychopharmacology 24(7): 1121-1125, 2010

The emerging role of atypical antipsychotics in the treatment of tardive dyskinesia induced by other atypical antipsychotics. Journal of Clinical Psychiatry 72(7): 1016; Author Reply 1016-7, 2011

Prevalence of tardive dyskinesia in chronic male inpatients with schizophrenia on long-term clozapine versus typical antipsychotics. International Clinical Psychopharmacology 29(6): 318-321, 2015

Tardive dyskinesia in patients treated with atypical antipsychotics: case series and brief review of etiologic and treatment considerations. Drugs in Context 3: 212259, 2014

Atypical antipsychotics and tardive dyskinesia. Journal of Managed Care Pharmacy 8(4): 291-292, 2003

Incidence of tardive dyskinesia in older adult patients treated with olanzapine or conventional antipsychotics. Journal of Geriatric Psychiatry and Neurology 28(1): 67-79, 2015